蓝光膀胱镜检出白光不可见浸润性膀胱肿瘤:多中心登记研究
基于多中心Cysview登记数据库,评估蓝光膀胱镜(BLC)检出白光膀胱镜(WLC)不可见浸润性肿瘤的作用。3514个病灶中818个(23.2%)为白光阴性/蓝光阳性(WL-/BL+),其中55个(7%)为浸润性(≥T1),47例患者中21例(45%)合并原位癌或其他T1病灶;22例WL-/BL+病灶患者行根治性膀胱切除术(RC),18例(82%)的高危病理特征仅BLC可见,RC时11例(50%)病理升级。
要点
- WL-/BL+病灶中7%为浸润性(≥T1),51%为原发浸润灶。
- WL-/BL+且行RC患者中82%的高危病理特征仅BLC可见。
- RC时50%患者病理升级,18%淋巴结阳性。
核心结论
- 相当比例浸润性膀胱肿瘤仅BLC可检出,且病理升级率显著,提示BLC对浸润性肿瘤检出有额外获益并影响治疗决策。
研究设计与样本
- 多中心Cysview登记数据库回顾性分析,共3514个病灶(1257例独特患者),纳入至少一个WL-/BL+病灶且最高分期为浸润性(≥T1)的患者。
主要发现
- 818个(23.2%)病灶为WL-/BL+,其中55个(7%)为浸润性(48个T1,7个T2;47例独特患者),28/55(51%)为原发浸润性病灶(26例独特患者)。
- 47例患者中21例(45%)合并WL-/BL+的原位癌和/或其他T1病灶。
- 22例WL-/BL+病灶患者行RC,18例(82%)的高危病理特征仅BLC可见;RC时11/22(50%)病理升级,其中4例(18%)淋巴结阳性。
临床怎么用
- BLC可检出WLC不可见的浸润性膀胱肿瘤,应关注WL-/BL+病灶的活检与分期,其检出可能影响RC等治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the role of blue-light cystoscopy (BLC) in detecting invasive tumours that were not visible on white-light cystoscopy (WLC). PATIENTS AND METHODS: Using the multi-institutional Cysview registry database, patients who had at least one white-light negative (WL-)/blue-light positive (BL+) lesion with invasive pathology (≥T1) as highest stage tumour were identified. All WL-/BL+ lesions and all invasive tumours in the database were used as denominators. Relevant baseline and outcome data were collected. RESULTS: Of the 3514 lesions (1257 unique patients), 818 (23.2%) lesions were WL-/BL+, of those, 55 (7%) lesions were invasive (48 T1, seven T2; 47 unique patients) including 28/55 (51%) de novo invasive lesions (26 unique patients). In all, 21/47 (45%) patients had WL-/BL+ concommitant carcinoma in situ and/or another T1 lesions. Of 22 patients with a WL-/BL+ lesion who underwent radical cystectomy (RC), high-risk pathological features leading to RC was only visible on BLC in 18 (82%) patients. At time of RC, 11/22 (50%) patients had pathological upstaging including four (18%) with node-positive disease. CONCLUSIONS: A considerable proportion of invasive lesions are only detectable by BLC and the rate of pathological upstaging is significant. Our present findings suggest an additional benefit of BLC in the detection of invasive bladder tumours that has implications for treatment approach.
引用
- Ahmadi H, Ladi-Seyedian SS, Konety B, et al. Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry. BJU Int. 2021. PMID: 34637596. doi:10.1111/bju.15614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。